2005年至2024年心血管疾病中的P2X7R的图书法测量分析
Juanjuan Tan1,2, Wenqi Zhou3, Zhiye Guo4
1Institute of Integrative Medicine, Shaanxi University of Chinese Medicine, Xianyang, 712046, China.
Current cardiology reviews
|June 27, 2025
概括
这项研究分析了心血管疾病中的P2X7受体研究,确定中国是最具生产力的国家. 新兴趋势强调纯能信号和氧化应激是未来P2X7R研究的关键领域.
科学领域:
- 心血管研究研究心血管研究
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- P2X7受体 (P2X7R) 在炎症中起作用,与各种疾病有关,包括心血管功能障碍.
- 对心血管疾病中P2X7R的研究正在增加,需要进行全面的文献计量评估.
研究的目的:
- 在心血管疾病中进行P2X7受体研究的第一个图书统计分析.
- 确定关键的研究趋势,有影响力的国家,机构和作者在这个领域.
主要方法:
- 从2005年到2024年在科学网络核心集合中发表的371篇文章的图书统计分析.
- 利用CiteSpace和VOSviewer进行数据分析和对国家,机构,作者,期刊和关键词的可视化.
主要成果:
- 中华人民共和国,南大学",纯能信号"和山东梁是最具生产力的实体.
- 最受欢迎的关键词包括"激活"",p2x7受体"",ATP"和"炎症".
- 发现的新兴研究热点是"纯能信号"和"氧化应激".
结论:
- 这项研究提供了P2X7R在心血管疾病中的第一个文献统计概述,突出了当前的研究重点.
- 纯能信号,炎症和氧化应激之间的相互作用是未来心血管研究的重要焦点.
- 这些发现为指导未来研究P2X7R在心血管健康和疾病中的作用提供了宝贵的见解.
相关概念视频
Coronary Artery Disease II: Pathophysiology
42
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
42
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
352
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
352
Ischemic Heart Disease: Overview
1.4K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
70
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
70
Cardiovascular Drugs: Classification based on Therapeutic Indications
3.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.2K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
653
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
653


